Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value
$119.44M
Total Bought
$72.94M
Total Sold
$77.15M
Net Transaction
-$4.21M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MADRIGAL PHARMACEUTICALS INC(MDGL)032,662+32,662014,98112.54%+14,981
ATAI BECKLEY NV02,287,005+2,287,005012,09810.13%+12,098
ASCENDIS PHARMA A/S - ADR(ASND)051,080+51,080010,1558.50%+10,155
TAYSHA GENE THERAPIES INC(TSHA)01,898,112+1,898,11206,2075.20%+6,207
AMYLYX PHARMACEUTICALS INC(AMLX)0437,391+437,39105,9444.98%+5,944
SOLENO THERAPEUTICS INC178,819302,483+123,66414,98120,44817.12%+5,466
EUPRAXIA PHARMACEUTICALS INC(EPRX)0915,000+915,00005,3994.52%+5,399
ARCUTIS BIOTHERAPEUTICS INC(ARQT)0233,220+233,22004,3963.68%+4,396
MONOPAR THERAPEUTICS INC(MNPR)34,53764,455+29,9181,2365,2644.41%+4,028
AVALO THERAPEUTICS INC(AVTX)0178,100+178,10002,2641.90%+2,264
PROMIS NEUROSCIENCES INC1,334,4286,233,497+4,899,0696462,6492.22%+2,004
COMPASS PATHWAYS PLC(CMPS)1,485,0001,026,382-458,6184,1585,8814.92%+1,723
WHITEHAWK THERAPEUTICS INC(WHWK)817,939817,93901,5301,5541.30%+25
SOLID BIOSCIENCES INC724,000549,182-174,8183,5263,3882.84%-137
MIND MEDICINE MINDMED INC726,172361,444-364,7284,7134,2613.57%-451
TARSUS PHARMACEUTICALS INC(TARS)121,18270,778-50,4044,9094,2063.52%-703
TECTONIC THERAPEUTIC INC(TECX)163,683138,595-25,0883,2522,1751.82%-1,078
ATYR PHARMA INC287,7200-287,7201,4590—-1,459
LENZ THERAPEUTICS INC(LENZ)343,322175,363-167,95910,0638,1686.84%-1,894
KORRO BIO INC(KRRO)154,2230-154,2231,9260—-1,926
PRAXIS PRECISION MEDICINES I(PRAX)80,8800-80,8803,4010—-3,401
LEXEO THERAPEUTICS INC(LXEO)867,3020-867,3023,4870—-3,487
AVIDITY BIOSCIENCES INC132,7440-132,7443,7700—-3,770
CENTESSA PHARMACEUTICALS PLC293,9860-293,9863,8630—-3,863
GERON CORP(GERN)3,251,4750-3,251,4754,5850—-4,585
INSMED INC(INSM)47,7100-47,7104,8020—-4,802
REPLIMUNE GROUP INC(REPL)528,4910-528,4914,9100—-4,910
ORIC PHARMACEUTICALS INC(ORIC)485,6290-485,6294,9290—-4,929
ENLIVEN THERAPEUTICS INC281,3940-281,3945,6450—-5,645
ULTRAGENYX PHARMACEUTICAL IN
CALL
1,6000-1,6005,8180—-5,818
MERUS N V140,2080-140,2087,3750—-7,375
VERONA PHARMA PLC160,7010-160,70115,1990—-15,199
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q3 2025 | TickerTrail